Filtered By:
Vaccination: Influenza Vaccine
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 364 results found since Jan 2013.
Preserved cellular immunity upon influenza vaccination in most patients with common variable immunodeficiency
Publication date: Available online 21 April 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): David Friedmann, Sigune Goldacker, Hans-Hartmut Peter, Klaus Warnatz
Source: The Journal of Allergy and Clinical Immunology: In Practice - April 22, 2020 Category: Allergy & Immunology Source Type: research
“Host immune response-inspired development of the influenza vaccine”
Influenza is a respiratory illness caused by influenza viruses. It is a major public health concern with a huge economic impact worldwide [1 –3]. Vaccines against influenza virus are the best method of protection. The very young, the elderly, pregnant women and immune-compromised individuals are at enhanced risk for severe complications during infection. Therefore, these individuals form special target groups for influenza vaccination. Due to the rise in life expectancy, the elderly population is growing in countries with an aging population.
Source: Annals of Allergy, Asthma and Immunology - April 19, 2020 Category: Allergy & Immunology Authors: Angela Choi, Adolfo Garc ía-Sastre, Michael Schotsaert Tags: Review Source Type: research
Host immune response –inspired development of the influenza vaccine
To assess the current and future development of influenza vaccines.
Source: Annals of Allergy, Asthma and Immunology - April 19, 2020 Category: Allergy & Immunology Authors: Angela Choi, Adolfo Garc ía-Sastre, Michael Schotsaert Tags: Review Source Type: research
"Host immune response-inspired development of the influenza vaccine".
PMID: 32325117 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - April 19, 2020 Category: Allergy & Immunology Authors: Choi A, García-Sastre A, Schotsaert M Tags: Ann Allergy Asthma Immunol Source Type: research
Vaccines, Antibodies and Drug Libraries. The Possible COVID-19 Treatments Researchers Are Excited About
In early April, about four months after a new, highly infectious coronavirus was first identified in China, an international group of scientists reported encouraging results from a study of an experimental drug for treating the viral disease known as COVID-19.
It was a small study, reported in the New England Journal of Medicine, but showed that remdesivir, an unapproved drug that was originally developed to fight Ebola, helped 68% of patients with severe breathing problems due to COVID-19 to improve; 60% of those who relied on a ventilator to breathe and took the drug were able to wean themselves off the machines after 18...
Source: TIME: Health - April 14, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
All Your Coronavirus Questions, Answered
One of the worst symptoms of any plague is uncertainty—who it will strike, when it will end, why it began. Merely understanding a pandemic does not stop it, but an informed public can help curb its impact and slow its spread. It can also provide a certain ease of mind in a decidedly uneasy time. Here are some of the most frequently asked questions about the COVID-19 pandemic from TIME’s readers, along with the best and most current answers science can provide.
A note about our sourcing: While there are many, many studies underway investigating COVID-19 and SARS-CoV-19, the novel coronavirus that causes the illn...
Source: TIME: Health - April 14, 2020 Category: Consumer Health News Authors: TIME Staff Tags: Uncategorized COVID-19 Explainer Source Type: news
How to Flatten the Curve on Coronavirus
One chart explains why slowing the spread of the infection is nearly as important as stopping it.
Source: NYT Health - March 27, 2020 Category: Consumer Health News Authors: Siobhan Roberts Tags: Coronavirus (2019-nCoV) Quarantines Epidemics Shortages Hospitals Vaccination and Immunization Influenza Hygiene and Cleanliness Centers for Disease Control and Prevention Economist, The National Institute of Allergy and Infectious Dis Source Type: news
President Trump Called Hydroxychloroquine a ‘Game Changer,’ But Experts Warn Against Self-Medicating With the Drug. Here’s What You Need to Know
After President Trump, late last week, expressed great confidence in the promise of a new COVID-19 therapy that combines two existing prescription medications, supplies of these two drugs rapidly began disappearing from pharmacy shelves. The U.S. Food and Drug Administration allowed an Indian company previously restricted from importing drug products into the US to now start manufacturing one of the drugs. And U.S. plants began gearing up to produce enough to meet the surge in demand.
But in those few days, a few people who began self medicating with the drugs in an effort to prevent COVID-19 have died, and others have bee...
Source: TIME: Health - March 24, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
Trump ’s State of Emergency Is an Admission of Failure by the U.S. Government
President Donald Trump’s declaration of a national emergency is designed to speed federal support to parts of America that are struggling to prepare for a coming surge of COVID-19 cases, unlocking $50 billion in aid, giving hospitals and doctors more freedom to handle a potential tsunami of sick patients and scrambling to make tests available. In a Rose Garden press conference Friday, Trump presented the emergency measures as proof that, “No nation is more prepared or more equipped to face down this crisis.”
But for epidemiologists, medical experts and current and former U.S. public health officials, the ...
Source: TIME: Health - March 13, 2020 Category: Consumer Health News Authors: W.J. Hennigan Tags: Uncategorized COVID-19 Source Type: news
Estimates of 2019-20 Seasonal Flu Vaccine Effectiveness Estimates of 2019-20 Seasonal Flu Vaccine Effectiveness
How effective has the seasonal influenza vaccine been during this most recent flu season? A new report provides interim estimates.Morbidity & Mortality Weekly Report
Source: Medscape Allergy Headlines - March 13, 2020 Category: Allergy & Immunology Tags: Public Health & Prevention Journal Article Source Type: news
Is It Allergies, The Flu Or The Coronavirus? How To Tell The Difference
(CNN) — The coronavirus has infected more than 100,000 people worldwide. With all of the news of event cancellations, empty flights and health precautions (wash your hands!), it’s natural that people may get a little anxious every time they feel a tickle in their throat or the beginnings of a bad cough.
While the coronavirus is certainly something to take seriously, the chances of any individual person getting it are still low. But if you’re wondering whether that stuffy nose could end up being a worst case scenario, CNN talked to Dr. Greg Poland, a professor of medicine and Infectious diseases at the May...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 11, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Coronavirus Source Type: news
World Health Organization Declares COVID-19 a ‘Pandemic.’ Here’s What That Means
The World Health Organization (WHO) on March 11 declared COVID-19 a pandemic, pointing to the over 118,000 cases of the coronavirus illness in over 110 countries and territories around the world and the sustained risk of further global spread.
“This is not just a public health crisis, it is a crisis that will touch every sector,” said Dr. Tedros Adhanom Ghebreyesus, WHO director-general, at a media briefing. “So every sector and every individual must be involved in the fights.”
An epidemic refers to an uptick in the spread of a disease within a specific community. By contrast, the WHO defines a pand...
Source: TIME: Health - March 11, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news
Licensure of a New Hexavalent Vaccine for Use in Infants Licensure of a New Hexavalent Vaccine for Use in Infants
A new hexavalent vaccine for use in children aged 6 weeks through 4 years has been approved by the FDA to prevent diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b, and hepatitis B.Morbidity & Mortality Weekly Report
Source: Medscape Allergy Headlines - March 2, 2020 Category: Allergy & Immunology Tags: Public Health & Prevention Journal Article Source Type: news
FDA OKs Quadrivalent, Adjuvanted Flu Vaccine for Older Adults FDA OKs Quadrivalent, Adjuvanted Flu Vaccine for Older Adults
The quadrivalent version of Fluad was safe and effective against influenza strains included in the vaccine in multiple clinical studies with adults aged 65 years or older.News Alerts
Source: Medscape Allergy Headlines - February 24, 2020 Category: Allergy & Immunology Tags: Infectious Diseases News Alert Source Type: news
Flu Vaccine Effectiveness Good This Season, CDC Says Flu Vaccine Effectiveness Good This Season, CDC Says
Preliminary estimates show influenza vaccine effectiveness for 2019-2020 was 55% in children and 45% overall, according to the Centers for Disease Control and Prevention.Medscape Medical News
Source: Medscape Allergy Headlines - February 20, 2020 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
